If a women begins her pregnancy with serum antibody already present, the risk of infection to the fetus is so small that it can be ignored. If there is a significant rise in antibody titre during the first trimester termination may be considered, but it is possible that the fetus is uninfected.
A significant rise in antibody during the last six months of pregnancy probably needs treatment with pyrimethamine, sulphadiazine and folinic acid or spiramycin.
Vaccines: If the lower incidence of congenital infection in the UK is due to less eating of raw meat, and most of the infection comes from cats, then possibly a vaccine for cats would be useful. It might, however, be difficult to persuade cat owners that it was necessary, and its efficacy is doubtful. There are considerable problems about producing an effective vaccine for human cases. Perhaps the wisest course is to encourage girls to play with cats, to acquire infection before pregnancy, but it might be dangerous to encourage the spread of infection if the acquired disease is found to produce retinitis. REFERENCES Congenital rubella has probably been the subject of more intensive clinical and laboratory study than any other intrauterine infection occurring in man. Although a great deal is known about the effects of this virus on the human fetus there are a number of questions which remain unanswered.
The first important considerations are the risks of fetal infection and fetal damage. It is probably correct to say that risk of infection of the fetus occurs only in a primary infection during pregnancy. The cases of reinfection in pregnancy which were studied in detail by Boue et al. (1971) failed to show that infection of the fetus had occurred. Strong evidence to support this view is found in the absence of any report of more than one case of congenital rubella in a family, other than the occurrence of infection in twins.
The incidence and extent of fetal damage is related to the age of the fetus at the time of intrauterine infection. This, however, has been difficult to determine accurately and a major factor is the frequency of subclinical maternai infection. I would not like to go beyond the figures quoted by Professor Dudgeon (1967) when he cited the risk for the birth of an infant with defects as being about 50 % when maternal infection occurs during the first month of pregnancy, 20 % in the second month and 7-8 % in the third and fourth months. On the other hand the incidence of fetal infection approaches 100% where the maternal infection occurs in the first 10-12 weeks of gestation, as has been shown by Rawls et al. (1968) and by Thompson & Tobin (1970) in their examination of fetal material from laboratory-proven cases of maternal infection. Intrauterine rubella infection can be demonstrated by serological means in infants and children who appear clinically normal. This suggests that infection can occur without fetal damage, or there is the possibility that damage occurs in utero, but can be repaired before birth. The effects of this virus on the fetus are outlined in Fig 1. At one end of this spectrum of effects the fetus may not survive because of a spontaneous or therapeutic abortion; then there may be the birth of an infant who may have structural defects and/or damage to anatomically normal tissues. Stillbirth is, surprisingly, not common. Whilst structural defects are permanent, other defects, such as thrombocytopenia, myocarditis and osteopathy are transient disease states. Meningoencephalitis, which may be present in early infancy, is identifiable by raised protein and cells and the presence of virus in the CSF. This feature has not received a great deal of attention and its role in the causation of brain damage after birth cannot be readily dismissed.
In later infancy other clinical manifestations, though not common, may be encountered; there may be a chronic rash or a severe and often fatal pneumonitis. The pneumonitis is known to respond to corticosteriod therapy, which might suggest that immunopathological mechanisms may operate in the causation of the lung disease (Marshall 1973) . The rash and the lung disease occurring in late infancy could be called 'late onset disease'.
It is also now apparent that damage to the hearing mechanism may occur several years after birth. Peckham (1972) has demonstrated the onset of deafness between the ages of 2 and 7, and an increase in the severity of deafness may also occur. The disorders of hearing and speech in congenital rubella are very complex. Hearing defects are not always due to damage to the organ of Corti; they may be due to central damage and manifest as central auditory imperception (Ames et al. 1970 ). Recently, it has been suggested that language disorders with apparently normal hearing are part of the spectrum of defects (Pinsky et at. 1973) . In the evaluation of neurological disabilities in some of these children the possibility of autistic features must also be considered (Chess et al. 1971) . Soothill et al. (1966) detected hypogammaglobulinemia G in 18% of patients, and it has been observed by others in isolated cases. No further instances of IgG deficiency have since been observed in patients at this hospital, and only an occasional patient with IgA deficiency; clearly hypogammaglobulinmnia is not as frequent as was first thought. Cooper and his associates have found IgA deficiency in a number of congenital rubella patients (Lawton et al. 1972) ; as IgA deficiency is one of the most common congenital immunodeficiency state there may not be a causal relationship. However, in the management of these patients the' possibility of immunoglobulin deficiencies and their consequences must be considered.
Defective cell-mediated immunity (CMI) has been frequently suggested as the mechanism for persistence of the virus, but it has not been possible to provide satisfactory proof of this because of a lack of suitable methods to measure CMI to rubella in contrast to the more general defect which can be detected by responsiveness to phytohtemagglutinin. The recent report by Steele et al. (1973) on a method to measure CMI to rubella using target cell interaction with lymphocytes and release of 51Cr from rubella-infected cells may enable this question to be answered. A defect in CMI to rubella, perhaps of a temporary nature, may well exist in early life.
More information is required about the causation of fetal damage. There are several causes which probably vary in degree in individual cases. Although the virus is capable of causing death of cells, growth of cells may be delayed by the virus infecting, but not destroying the cells, or by a reduction in the rate of cell division mediated by the 'mitotic inhibitor' released from infected cells (Plotkin & Vaheri 1971) . The reduction or deprivation of blood supply to tissues by an obliterative angitis or by means of minute emboli is another mechanism of fetal damage. Finally, damage may ensue from immunopathological mechanisms.
The now widespread acceptance of live rubella vaccines has added another potential hazard to the fetus. Although contraindicated in a woman who is pregnant, or one who might become pregnant during the two months after vaccination, they have been given all too frequently in these circumstances, resulting in much anxiety and a considerable fetal wastage from therapeutic abortions.
A report from the United States cites 243 instances of inadvertent vaccination in pregnancy (Center for Disease Control 1973) . Unfortunately the immune status of 201 of these women at the time of vaccination was not known and only 35 women were known to be susceptible. Of these 243 pregnancies, 7 % ended in spontaneous abortion'and 51 % were terminated therapeutically.
No abnormalities were observed in the 112 liveborn infants and 36 in whom serological tests were performed showed only passively acquired maternal antibody. The infants born to 18 susceptible women showed no defects but this number is clearly too small to exclude the possibility of damage from the vaccine virus.
These encouraging findings have to be considered together with the evidence in the same report that virus was isolated from placenta, decidua, fetal marrow, kidney and eye. Of abortion specimens from susceptible women 30 % have contained virus and the infected tissues have been shown to have histopathological charges similar to wild virus infection.
Anxiety about inadvertent vaccination of the pregnant woman can be avoided if the instructions for use of the vaccines are correctly followed.
The effectiveness of rubella vaccines in the prevention of congenital rubella has yet to be proven and surveillance of congenital rubella is necessary to determine this, but it clearly depends on the efficiency of a surveillance programme. It is hoped that the National Congenital Rubella Surveillance Programme in the United Kingdom, based on centres in London and Leeds, will provide some of these answers. This programme has now been in operation for just over two years and the results of the first year have been published (Dudgeon et al. 1973) . Cases are referred from pediatricians and medical officers of health, the former generally referring details of patients with multiple defects and the latter, details of children with hearing defects. The diagnosis of congenital rubella in this programme is made by clinical and serological means. Information obtained from analysis of data from the first year has shown that in 28 % of cases there was no history of illness or contact with rubella in pregnancy, 48% of the children were first-born and 76% were born in the months from October to March. The year of birth of cases referred from July 1971 to December 1973 is shown in Table 1 . It can be seen that the numbers of cases are nowhere near the estimated 200 cases per year in the United Kingdom (Dudgeon 1972) .
Some of the reasons for this could be that neonatal deaths may not be reported, and it may take two to three years for a child to be reported. To maintain and perhaps to increase the present level of reporting will be a major undertaking. Surveillance must continue for a number of years because with the present rubella vaccination programme in this country it will be some time before the efficacy of the vaccines in preventing congenital rubella can be demonstrated. Hanshaw (1973) .
Infection with HVH during pregnancy can produce abortions and congenital defects in the fetus and perinatal disease in the newborn.
Abortions Naib et al. (1970) , in Atlanta, studied the incidence of abortions in 228 women with cervical smear evidence of HVH infection as compared with control groups. A third to a half of pregnancies in those with infection established before conception ended in abortion, the nearer to the pregnancy the infection being detected, the higher the abortion rate. Seven of 21 women with HVH infection diagnosed during the first 4 months of pregnancy also aborted. This compared with an abortion rate of about 10% in control groups without evidence of HVH infection. Of all the viruses found by these workers 95 % were Type 2. This virus type has also been isolated from a 7-week-old spontaneous aborted conceptus (Boue & Loffredo 1970) . How HVH causes abortion is not known, but an ascending infection from the recurrent cervical lesions is at the moment the most reasonable assumption. It is of interest that the rate of premature births was not significantly raised in this study and there was evidence that primary was more likely than recurrent infection to cause miscarriages.
Congenital Defects in the Fetus Only 6 cases have been described in which congenital defects have been ascribed to HVH. Microcephaly, intracranial calcification, diffuse brain changes, chorioretinitis, retinal dysplasias
